We are live on ! Find out more
Legal & General Group

Legal & General Group Portfolio holdings

AUM $432B
1-Year Est. Return 29.4%
 

Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.

This Quarter Est. Return
+9.31%
1 Year Est. Return
+29.4%
3 Year Est. Return
+97.7%
5 Year Est. Return
+129.51%
10 Year Est. Return
+472.83%
AUM
$210B
AUM Growth
+$20.2B
Cap. Flow
+$4.59B
Cap. Flow %
2.19%
Top 10 Hldgs %
17.72%
Holding
3,425
New
77
Increased
2,516
Reduced
317
Closed
57

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$261M
2
BABA icon
Alibaba
BABA
+$233M
3
TFC icon
Truist Financial
TFC
+$191M
4
MSFT icon
Microsoft
MSFT
+$160M
5
AMZN icon
Amazon
AMZN
+$133M

Sector Composition

Rank Sector Weight
1 Technology 19.21%
2 Financials 15.12%
3 Healthcare 12.68%
4 Consumer Discretionary 10.28%
5 Communication Services 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
3201
Lineage Cell Therapeutics
LCTX
$284M
$19K ﹤0.01%
21,170
OPBK icon
3202
OP Bancorp
OPBK
$236M
$19K ﹤0.01%
1,864
PDLB icon
3203
Ponce Financial Group
PDLB
$497M
$19K ﹤0.01%
1,846
PSNL icon
3204
Personalis
PSNL
$1.44B
$19K ﹤0.01%
1,764
+286
+19% +$2.98K
VIR icon
3205
Vir Biotechnology
VIR
$1.55B
$19K ﹤0.01%
+1,482
New +$19.9K
VIA
3206
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$19K ﹤0.01%
418
+93
+29% +$4.65K
SOGO
3207
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$19K ﹤0.01%
4,278
PRGX
3208
DELISTED
PRGX Global, Inc.
PRGX
$19K ﹤0.01%
3,945
+855
+28% +$4.14K
BTAI icon
3209
BioXcel Therapeutics
BTAI
$27.4M
$18K ﹤0.01%
77
+14
+22% +$1.41K
CRK icon
3210
Comstock Resources
CRK
$3.88B
$18K ﹤0.01%
2,392
GENC icon
3211
Gencor Industries
GENC
$223M
$18K ﹤0.01%
1,529
+55
+4% +$662
NEXT icon
3212
NextDecade
NEXT
$1.77B
$18K ﹤0.01%
2,902
+1,431
+97% +$8.91K
SGA icon
3213
Saga Communications
SGA
$59.4M
$18K ﹤0.01%
602
XGN icon
3214
Exagen
XGN
$147M
$18K ﹤0.01%
+710
New +$12.6K
STSA
3215
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$18K ﹤0.01%
+910
New +$12.9K
PHAS
3216
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$18K ﹤0.01%
2,895
+612
+27% +$2.52K
ABEO icon
3217
Abeona Therapeutics
ABEO
$374M
$17K ﹤0.01%
212
BBCP icon
3218
Concrete Pumping Holdings
BBCP
$495M
$17K ﹤0.01%
3,075
+1,246
+68% +$5.08K
FULC icon
3219
Fulcrum Therapeutics
FULC
$289M
$17K ﹤0.01%
1,028
+152
+17% +$1.45K
GCBC icon
3220
Greene County Bancorp
GCBC
$587M
$17K ﹤0.01%
1,162
+216
+23% +$3.02K
KALA icon
3221
KALA BIO
KALA
$14.6M
$17K ﹤0.01%
2
RPAY icon
3222
Repay Holdings
RPAY
$339M
$17K ﹤0.01%
+1,166
New +$16.3K
SLDB icon
3223
Solid Biosciences
SLDB
$841M
$17K ﹤0.01%
253
+8
+3% +$883
MORF
3224
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$17K ﹤0.01%
992
+182
+22% +$2.84K
ELVT
3225
DELISTED
Elevate Credit, Inc.
ELVT
$17K ﹤0.01%
3,907
+614
+19% +$2.56K

Similar funds

Legal & General Group's Q4 2019 Portfolio in Review

As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
  • Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
  • Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
  • Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
  • Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
  • Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
  • Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.

Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.